These results underscore the importance of astrocytic endocannabinoid signaling in the developmental origins of AD and support further investigation using PEE-exposed 3×Tg-AD mice in longitudinal designs on GPR55/PEA as a potential therapeutic target to guide future strategies aimed at mitigating the long-term effects of prenatal insults on brain health. This evidence concerns the gene GPR55 and Alzheimer disease.